Survival rate of multi-drug resistant tuberculosis among human immunodeficiency virus co-infected patients in Sanglah Hospital/Udayana University, Bali, Indonesia: a cohort retrospective study

Introduction: Tuberculosis (TB) and human immunodeficiency virus (HIV) are corelated infectious diseases and their worldwide spread became a global health problem. Moreover, HIV patients with TB are able to develop multi-drug resistance tuberculosis (MDR-TB) and extensive drug-resistant TB (XDR-TB), which make treatments more challenging and affect survival rate. This study aimed to observe survival rate of HIV-positive patients with MDR-TB.